Steven De Jonghe
Papers
1
Total Citations
14
H-Index
1
About
Steven De Jonghe is a leading antiviral researcher whose work has been instrumental in the fight against SARS-CoV-2. His primary focus lies in the development of innovative high-throughput screening (HTS) technologies to accelerate drug discovery. His most notable contribution is the creation of a robust, dual-reporter HTS assay for identifying SARS-CoV-2 antivirals, a method that enables rapid, automated testing of thousands of compounds. This assay, detailed in his 2022 highly cited paper (14 citations), has become a cornerstone for researchers seeking to repurpose existing drugs or discover new ones against COVID-19. By streamlining the path from compound to candidate, De Jonghe’s work directly supports the global effort to build a more resilient antiviral arsenal, demonstrating the critical role of assay development in pandemic preparedness.
Research Focus
Key Achievements
Top Papers
- 1